Assessment of formulation robustness for nano-crystalline suspensions using failure mode analysis or derisking approach

[Display omitted] The small particle size of nano-crystalline suspensions can be responsible for their physical instability during drug product preparation (downstream processing), storage and administration. For that purpose, the commercial formulation needs to be sufficiently robust to various tri...

Ausführliche Beschreibung